Get access to our best features
Get Started
Subscribe
Get access to our best features
Get Started
healthstockshub.com image

healthstockshub.com

Information about healthstockshub.com

Where is healthstockshub.com located?healthstockshub.com's Website

Factuality

How credible is the news from healthstockshub.com?
Unknown
by Ad Fontes Media and Media Bias/Fact Check
Learn more about Factuality Ratings.

Media Bias Ratings

Does healthstockshub.com lean left or right?
Learn more about Media Bias Ratings.

Top healthstockshub.com News

Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update - Adamis Pharmaceuticals (NASDAQ:ADMP)

Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update - Adamis Pharmaceuticals (NASDAQ:ADMP)

50% Center coverage: 4 sources
BioNTech SE (Nasdaq: BNTX) will announce its financial results for the full year and fourth quarter 2022 on March 27th, 2023. The Company invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT.See the Story
Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

75% Center coverage: 4 sources
BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. The Company's fourth quarter and full year 2022 financial results will be released after market close on Thursday, March 16, 2023. Management will provide an overview of the Company's financial results.See the Story
Noodles & Company Announces Fourth Quarter and Full Year 2022 Financial Results - Noodles (NASDAQ:NDLS)

Noodles & Company Announces Fourth Quarter and Full Year 2022 Financial Results - Noodles (NASDAQ:NDLS)

100% Center coverage: 2 sources
MongoDB delivered a strong finish to fiscal 2023, highlighted by 50% Atlas revenue growth and continued strength in winning new customers and workloads. "We are incredibly optimistic about the opportunity ahead for MongoDB as we continue to disrupt one of the largest markets in software," said Dev Ittycheria, CEO of MongoDB.See the Story

Latest News Stories

Real Estate

Vantage Drilling International Schedules Fourth Quarter 2022 Earnings Release Date and Conference Call

67% Center coverage: 3 sources
Vantage will release earnings before the market opens on March 23, 2023. Vantage's earnings release will be posted to the Vantage website at www.vantagedrilling.com. A replay of the conference call will be available following the call and can be accessed via Webcast Link.See the Story
Business

Kuaishou Technology to Report Fourth Quarter and Full Year 2022 Financial Results on March 29, 2023 - Kuaishou Tech (OTC:KSHTY)

75% Center coverage: 4 sources
Kuaishou Technology will report its financial results for the fourth quarter and full fiscal year ended December 31, 2022, after the Hong Kong market closes on Wednesday, March 29, 2023. The Company's management will host a conference call to discuss the results at 7:00 PM Beijing Time (7:00 AM U.S. Eastern Time)See the Story

LIZHI INC. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Thursday, March 16, 2023 - Lizhi (NASDAQ:LIZI)

100% Center coverage: 2 sources
Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF) will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022 before market open on March 28, 2023. Management will host a conference call and audio webcast that morning at 8:30 a.m. ET.See the Story
Business

Why Adaptimmune (ADAP) Stock Is Plunging Today - TCR2 Therapeutics (NASDAQ:TCRR), Adaptimmune Therapeutics (NASDAQ:ADAP)

100% Center coverage: 2 sources
Adaptimmune Therapeutics, a cell therapy developer with offices in Philadelphia and the United Kingdom, is acquiring TCR² Therapeutics of Cambridge, Massachusetts, in an all-stock transaction. Under the terms of the deal, AdaptImmune (NASDAQ: ADAP) shareholders will own 75% of the combined company. TCR² (NASDAQ: TCRR) stockholders will receive 1.51 Adaptimmune American depository shares for each TCR² share they own, giving them the remaining 25%…See the Story

Baozun to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results on March 22, 2023 - Baozun (NASDAQ:BZUN)

100% Center coverage: 2 sources
Yatsen Holding Limited announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022. Total net revenues for the full year of 2022 decreased by 36.5% to RMB3.71 billion (US$537.3 million) from RMB5.84 billion for the prior year period.See the Story
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogSubscribeGiftFree TrialCareersFor Educators/LibrariesAffiliates
HelpHelp CenterFAQContact UsMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsBrowser ExtensionRehashTwitter BlindspotterDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyTerms and Conditions
© 2023 Snapwise Inc.
News
For You
Search
BlindspotLocal